BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home
»
Topics
»
Disease categories and therapies
» Nephrology
Nephrology
RSS
NC-1800 now in phase II development
Sep. 15, 1997
PharmaPrint begins phase II trial of herbal treatment for BPH
Sep. 11, 1997
Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden
Sep. 9, 1997
Agents useful for BPH from Pfizer
Sep. 9, 1997
Attenuation of cyclophosphamide-induced bladder damage in animals by GR-203040
Sep. 9, 1997
Uroselective alpha1-adrenoceptor antagonists for BPH
Sep. 8, 1997
Antioxidant from Otsuka effective in animal model of nephritis
Sep. 5, 1997
New aldosterone antagonists from Yamanouchi
Aug. 26, 1997
ETA/ETB antagonist protects against renal insufficiency in canine model
Aug. 19, 1997
Clinical trial results announced for novel incontinence therapeutic
Aug. 18, 1997
Previous
1
2
…
316
317
318
319
320
321
322
323
324
…
337
338
Next
RSS